Journal Report

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY

Download PDF
Journal Information
Journal Title
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
Publisher
SPRINGER
ISSN
2210-7703
E-ISSN
2210-7711
Database
Clarivate
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Pharmacovigilance signal detection of rilonacept using FAERS with exploratory Mendelian randomization analysis
Lihong Liu, Zhenfei Chi, Zhe Zhang
2026-10-1
Efficacy and safety of IL-23p19 antagonists versus placebo in inflammatory bowel disease: a systematic review and meta‑analysis of randomized controlled trials
Xi-Yuan Peng, Wei Du, Juan Miao et al.
2025-11-13 Vol. 47 Issue 6 Pages 1674-1687
Islamic reasoning and the use of prohibited medicines among Muslim patients: a qualitative study
Zachariah Nazar, Bilal Ali, Paul Rutter et al.
2025-11-12 Vol. 47 Issue 6 Pages 2083-2093
Correction: European Society of Clinical Pharmacy: 5 steps of medication safety—medication without harm, where are we now?
Anita Elaine Weidmann, Monika Lutters
2025-11-6 Vol. 47 Issue 6 Pages 2101-2101
Economics, efficacy and safety of five traditional Chinese medicine injections plus chemotherapy as adjuvant therapy for non-small cell lung cancer: A network meta-analysis
Kai Xu, Hongtao Li, Yulu Zhu et al.
2025-10-30 Vol. 47 Issue 6 Pages 1688-1700
Medication safety in patients with hepatic disease: proof of concept of a new approach to screen for patients at risk—a retrospective evaluation utilizing electronic prescribing systems
Dorothea Strobach, Alina Grebe, Julian Steinbrech et al.
2025-10-30 Vol. 47 Issue 6 Pages 2027-2036
Exploring pediatricians’ off-label prescribing behavior in China: A theory of planned behavior-based study
Yueqin Zhang, Xuelin Sun, Dong Wang et al.
2025-10-29 Vol. 47 Issue 6 Pages 2072-2082
Comparative evaluation of pregnancy-related adverse events associated with proton pump inhibitors using the FDA adverse event reporting system database
Wenjuan Dong, Yuye Ran, Yiwen Cai et al.
2025-10-23 Vol. 47 Issue 6 Pages 2051-2060
Real-world safety assessment of ublituximab: a pharmacovigilance analysis based on the FDA adverse event reporting system
Sen Luo, Yining Feng, Zhuo Huang et al.
2025-10-21 Vol. 47 Issue 6 Pages 2017-2026
Effectiveness and safety of different antiplatelet therapies for minor ischemic stroke or high-risk transient ischemic attack: a systematic review and network meta-analysis
Tingting Jin, Huifang Jiang, Guoquan Chen et al.
2025-10-21 Vol. 47 Issue 6 Pages 1660-1673
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 31, 2026 14:31